Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Sam Brown is an independent healthcare communications agency specializing in public relations and strategic communications for biotechnology, pharmaceutical, medical device companies and related healthcare organizations. The firm was acquired by Blue Matter in September 2024 but continues to operate under its own name with founder Laura Liotta leading the agency as part of Blue Matter’s executive team[2][5].
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Sam Brown.